The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

A study led by Harvard Medical School, explored the reason that causes the rise of aortic aneurysms, thus offering vital ...

The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...

The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable. This new drug promises better adherence and wider access, especially in ...

President Trump announces US airstrikes on Iran's nuclear sites Fordow, Natanz, and Isfahan, marking a direct intervention in ...

Israeli PM Benjamin Netanyahu praises US President Donald Trump for striking Iran's nuclear facilities, foreseeing a future ...

Speaking at a two-day training retreat at the Source of the Nile Hotel, Dr. Egessa Simplicious, Public Relations Officer at ...

Sarah Kasadha, the Deputy Resident District Commissioner (RDC), criticized the growing trend as a sign of declining ...